{
  "meta": {
    "timestamp": "2025-01-06T12:31:46.053726",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Procept Biorobotics Corp",
      "symbol": "PRCT",
      "analysis": {
        "historical": {
          "risk_score": 50,
          "key_risks": [
            "Regulatory and compliance risks due to dependence on approvals like FDA and CE Mark",
            "Intense competition from established players like Intuitive Surgical and emerging startups",
            "Adoption barriers due to high upfront costs and specialized surgeon training requirements",
            "Supply chain vulnerabilities from reliance on third-party suppliers",
            "Ethical and safety concerns related to surgical outcomes and potential adverse events"
          ],
          "controversies": [
            "Potential adverse events or controversies related to surgical outcomes",
            "Regulatory scrutiny and delays in approvals"
          ],
          "environmental_issues": [],
          "social_issues": [
            "High upfront costs may limit access to advanced surgical treatments in cost-sensitive markets"
          ],
          "governance_issues": [
            "Compliance risks associated with regulatory approvals and ongoing scrutiny"
          ],
          "recommendation": "caution",
          "confidence_score": 75
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "PDF",
              "snippet": "ANNUAL DECLARATION OF COMPLIANCE PROCEPT BioRobotics Corporation (\"PROCEPT\") is committed to the highest ethical standards and responsible decision-making in its interactions with healthcare professionals. believes that PROCEPT adherence to all applicable laws, regulations, and industry standards are critical to PROCEPT's operations",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370250+00:00",
              "published_date": null,
              "source_hash": "23be90023b240e6febc7300b29468ef9"
            },
            {
              "url": "",
              "title": "Investor Relations | PROCEPT BioRobotics Corp",
              "snippet": "The Investor Relations website contains information about PROCEPT BioRobotics Corp's business for ... Ms. Nouri has advised on corporate, transactional, and regulatory compliance matters including corporate governance, strategic transactions, mergers and acquisitions, intellectual property portfolio management, public disclosure issues, and SEC ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370356+00:00",
              "published_date": null,
              "source_hash": "23ab04804fa1a9077a47f46a7554b55b"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Sr. Director, Global Regulatory Affairs 150 Baytech Drive San Jose, California 95134 Re: K240200 ... PROCEPT BioRobotics Corporation \u00b7 150 Baytech Drive \u00b7 San Jose, CA 95134 office: +1.650.232.7200 \u00b7 info@PROCEPT-BioRobotics.com 510(k) SUMMARY . Date Prepared: August 19, 2024 .",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370370+00:00",
              "published_date": null,
              "source_hash": "ccf6087933e138bfbd9282b5d85c749f"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corporation",
              "snippet": "Page 1 of 13. PROCEPT BioRobotics Corporation . Code of Business Conduct and Ethics . I. INTRODUCTION A. Purpose This Code of Business Conduct and Ethics (the \" Code\") contains general guidelines for conducting the business of PROCEPT BioRobotics Corporation (the \"Company\" or \"we\") consistent with the highest standards of business ethics.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370384+00:00",
              "published_date": null,
              "source_hash": "52848bf49cc8f3f9d4446e98f695cf58"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corporation Corporate Governance Guidelines",
              "snippet": "PROCEPT BioRobotics Corporation . Corporate Governance Guidelines . The Board of Directors (the \"Board\") of PROCEPT BioRobotics Corporation (the \"Company\") has adopted the following Corporate Governance Guidelines (the \"Guidelines\") to assist the Board in the exercise of its responsibilities and to serve the interests of the Company and its stockholders.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370393+00:00",
              "published_date": null,
              "source_hash": "be206cdad82dd7a29b56c4348e61dd0f"
            },
            {
              "url": "",
              "title": "Washington Health Data Regulations Compliance | PROCEPT BioRobotics",
              "snippet": "Understand Washington's health data regulations and how PROCEPT BioRobotics ensures compliance with consumer health privacy laws to protect sensitive data. ... court order, legal process, government or regulatory requirement or to protect the safety, rights or property of the public or PROCEPT BioRobotics. ... and the PROCEPT BioRobotics logo ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370405+00:00",
              "published_date": null,
              "source_hash": "ce2bb35f47fa9ce4a8559597a8145d3c"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corp. ESG Risk Rating - Sustainalytics",
              "snippet": "PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370413+00:00",
              "published_date": null,
              "source_hash": "18b10c202443d6dc33ccc4c7eea0b5ac"
            },
            {
              "url": "",
              "title": "Procept Biorobotics Corp (PRCT) 10K Annual Reports & 10Q SEC Filings",
              "snippet": "The following information was filed by Procept Biorobotics Corp (PRCT) on Tuesday, February 27, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. ... insurance, compliance with the rules and regulations of the SEC and those of any stock exchange on which our securities ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370422+00:00",
              "published_date": null,
              "source_hash": "0c65deb36d4520531f6ef8ff6ef52572"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics\u00ae Receives U.S. FDA Investigational Device Exemption ...",
              "snippet": "The IDE approval allows PROCEPT BioRobotics to initiate a single-arm feasibility study in the United States. The data generated from this IDE study will support future research and regulatory ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370431+00:00",
              "published_date": null,
              "source_hash": "85e6e22e3506548138124fcad089b4f8"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corporation - Filings and Transcripts - BamSEC",
              "snippet": "PROCEPT BioRobotics Corporation Watch . NASDAQ: PRCT Share price (12/31/24): $80.52 Market ... BioRobotics\u00ae Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance 10/28/24 8-K Other Events ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:17.370441+00:00",
              "published_date": null,
              "source_hash": "3db76b38582d804757fea7fba284579b"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics",
              "snippet": "PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:30.855607+00:00",
              "published_date": "2025-01-03T00:00:00+00:00",
              "source_hash": "c3d05a9fc5dfdcb7ed630497e2466d05"
            },
            {
              "url": "",
              "title": "5 Analysts Assess PROCEPT BioRobotics: What You Need To Know",
              "snippet": "PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:30.855708+00:00",
              "published_date": "2024-12-02T09:00:00+00:00",
              "source_hash": "570b311d4ece435baf889866489d2cea"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Reaches Analyst Target Price",
              "snippet": "In recent trading, shares of PROCEPT BioRobotics Corp (Symbol: PRCT) have crossed above the average analyst 12-month target price of $97.38, changing hands for $99.45/share. When a stock reaches ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:26.906620+00:00",
              "published_date": "2024-12-05T12:43:00+00:00",
              "source_hash": "cca49400a340cc88786a24c0fc0449d8"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday",
              "snippet": "Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT) rose sharply during Monday's session after the company reported better-than-expected third-quarter financial results and raised its FY24 ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:26.906426+00:00",
              "published_date": "2024-10-28T15:27:00+00:00",
              "source_hash": "d26659fa2fd45ad43c29debf69c4c85e"
            },
            {
              "url": "",
              "title": "Morgan Stanley issues Overweight rating on Procept BioRobotics stock, sees continued growth",
              "snippet": "On Monday, Morgan Stanley (NYSE:MS) initiated coverage on Procept BioRobotics Corp (NASDAQ: PRCT) with an Overweight rating and set a price target of $105.00. Trading at $95.59, the stock has ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:31:19.919111+00:00",
              "published_date": "2024-12-02T07:29:00+00:00",
              "source_hash": "8e3d77155806966006c7813116691258"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corp SEC 10-Q Report - TradingView",
              "snippet": "PROCEPT BioRobotics Corp, a leading surgical robotics firm specializing in urology, has released its Form 10-Q report for the quarter ended September 30, 2023. The report highlights significant financial growth, strategic initiatives, and emerging challenges as the company continues to advance patient care through innovative robotic systems.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505230+00:00",
              "published_date": null,
              "source_hash": "e572871a56419ad8614855eb9e40f4a1"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics\u00ae Reports Third Quarter 2024 Financial Results and ...",
              "snippet": "SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the \"Company\"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended September 30, 2024. Recent Highlights",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505342+00:00",
              "published_date": null,
              "source_hash": "d78c06a2359488caaaddd9a92bc9b66d"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corp (PRCT) Q3 2024 Earnings Call Highlights ...",
              "snippet": "PROCEPT BioRobotics Corp (NASDAQ:PRCT) reported a strong financial performance with a 66% revenue growth in Q3 2024 compared to Q3 2023. The company achieved a record gross margin of 63.2% ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505378+00:00",
              "published_date": null,
              "source_hash": "1437e86576a9a2341c8c9f6b9a665d9c"
            },
            {
              "url": "",
              "title": "Procept Biorobotics 10-Q (2021-Q3)",
              "snippet": "PROCEPT BioRobotics Corporation (the \"Company\") was incorporated in the state of California in 2007 and its headquarters are located in Redwood City, California. ... The Company has initiated voluntary recalls for a limited number of handpieces due to certain issues related to supply chain and manufacturing processes, of which the provision ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505404+00:00",
              "published_date": null,
              "source_hash": "c96c2894eef9f26b852d93ee0ee46bef"
            },
            {
              "url": "",
              "title": "Press Release Details - PROCEPT BioRobotics Corp",
              "snippet": "SAN JOSE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics \u00ae Corporation (Nasdaq: PRCT) (the \"Company\"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financial results for the year ended December 31, 2023.. Recent Highlights . Total revenue of approximately $43.6 million for the fourth quarter ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505428+00:00",
              "published_date": null,
              "source_hash": "adef199271839bd58d168d22bde1214b"
            },
            {
              "url": "",
              "title": "Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats ...",
              "snippet": "PROCEPT BioRobotics (NASDAQ:PRCT) stock is trading on Monday after the company released better-than-expected third-quarter earnings. The company reported EPS loss of $(0.40), down from $(0.51) a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505454+00:00",
              "published_date": null,
              "source_hash": "b8a5f83a9c13fb6168ab15f1859223c2"
            },
            {
              "url": "",
              "title": "Procept BioRobotics, A Top 5% Stock, Is Making A Bullish Move On Its ...",
              "snippet": "Hydros is Procept BioRobotics' next-generation aquablation system. The company boosted its sales outlook for the year to $222.5 million to $223 million, up from an earlier midpoint of $217 million.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505476+00:00",
              "published_date": null,
              "source_hash": "90c67e1de058d4fb4a338c9e79d735e0"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics\u00ae Reports Second Quarter 2024 Financial Results and ...",
              "snippet": "SAN JOSE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the \"Company\"), a surgical robotics company focused on advancing patient care by developing ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505497+00:00",
              "published_date": null,
              "source_hash": "2766ad2386fd5762478725b3fb98725b"
            },
            {
              "url": "",
              "title": "Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics (PRCT ... - Nasdaq",
              "snippet": "A downtrend has been apparent in PROCEPT BioRobotics Corporation (PRCT) lately with too much selling pressure. The stock has declined 15.7% over the past four weeks. However, given the fact that ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505520+00:00",
              "published_date": null,
              "source_hash": "66025b52b58c5a73fa8132fc06cc1c5c"
            },
            {
              "url": "",
              "title": "Procept Biorobotics Shares Rise on Narrowed Loss, Raised Guidance",
              "snippet": "Shares in Procept Biorobotics rose after the company beat expectations with a narrowed third-quarter loss and lifted its outlook for 2024. Shares were up 14.3% at $78.60 in premarket trading.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp supply chain disruptions",
              "retrieved_at": "2025-01-06T19:31:23.505542+00:00",
              "published_date": null,
              "source_hash": "8eec3cf1f914b34dad0e2c55fafe0257"
            },
            {
              "url": "",
              "title": "Safety Information for HCPs | PROCEPT BioRobotics",
              "snippet": "All surgical treatments have inherent and associated side effects. Individual's outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522159+00:00",
              "published_date": null,
              "source_hash": "f7e8c3edb089ba1076d99b7254af0531"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "PROCEPT BioRobotics Corporation \u00b7 150 Baytech Drive \u00b7 San Jose, CA 95134 office: +1.650.232.7200 \u00b7 info@PROCEPT-BioRobotics.com 510(k) SUMMARY . Date Prepared: August 19, 2024 . Owner/Sponsor . PROCEPT BioRobotics Corporation . 150 Baytech Drive, San Jose, 95134 . USA . Submitter . Contact Name: Sara Muddell",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522261+00:00",
              "published_date": null,
              "source_hash": "646af59bdc7430af2c598382f99199ee"
            },
            {
              "url": "",
              "title": "Healthcare Provider Resources for Aquablation | PROCEPT BioRobotics",
              "snippet": "Safety and Efficacy of Same Day Discharge for Men Undergoing Contemporary Robotic-assisted Aquablation Prostate Surgery in an Ambulatory Surgery Center Setting\u2014First Global Experience ... Individual's outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522279+00:00",
              "published_date": null,
              "source_hash": "4d566d9a4d609c80d99249139ecdbbfb"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics\u00ae Receives U.S. FDA Investigational Device Exemption ...",
              "snippet": "REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (\"PROCEPT BioRobotics\"), a global leader in surgical robotics, announced today the ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522293+00:00",
              "published_date": null,
              "source_hash": "fa523982afac8889f4ad68d654e19409"
            },
            {
              "url": "",
              "title": "Investor Relations | PROCEPT BioRobotics Corp",
              "snippet": "SAN JOSE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics\u00ae Corporation (NASDAQ: PRCT) (\"PROCEPT BioRobotics\" or the \"Company\"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the pricing of an...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522431+00:00",
              "published_date": null,
              "source_hash": "38fec077b0ad97ac95940984dc063298"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics wins FDA IDE for aquablation trial in prostate ...",
              "snippet": "The US Food and Drug Administration (FDA) has awarded Procept Biorobotics an investigational device exemption (IDE), greenlighting a pivotal trial to test the company's aquablation therapy to treat prostate cancer.. The trial, known as WATER IV PCa, is a global multicentre, prospective, randomised clinical study that will assess the safety and efficacy of PROCEPT's technology compared to ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522511+00:00",
              "published_date": null,
              "source_hash": "e3fb025cb685c74177988ff9f1e7581e"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal ...",
              "snippet": "SAN JOSE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics\u00ae Corporation (Nasdaq: PRCT) (the \"Company\"), a surgical robotics company focused on advancing patient care by ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522528+00:00",
              "published_date": null,
              "source_hash": "703f65cb85e394a1ee72e2dbf49eacde"
            },
            {
              "url": "",
              "title": "Corporate Profile - PROCEPT BioRobotics Corp",
              "snippet": "PROCEPT BioRobotics is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. We develop, manufacture and sell the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522540+00:00",
              "published_date": null,
              "source_hash": "a7464d43e383518d03287d3d23fc01d4"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Announces FDA Clearance of the HYDROS\u2122 Robotic ...",
              "snippet": "SAN JOSE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics\u00ae Corporation (Nasdaq: PRCT) (the \"Company\"), a surgical robotics company focused on advancing patient care by ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522552+00:00",
              "published_date": null,
              "source_hash": "a0a3d6bbd6bde93b06851c8737a17f36"
            },
            {
              "url": "",
              "title": "Aquablation Therapy Overview for HCPs | PROCEPT BioRobotics",
              "snippet": "Risk and Safety Information All surgical treatments have inherent and associated side effects. Individual's outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:28.522568+00:00",
              "published_date": null,
              "source_hash": "4f52cc8fcf4cacf0ded9c0f52ffd9d8f"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corporation (PRCT)",
              "snippet": "Sustainalytics' Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company's operations. Controversies ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:30.855739+00:00",
              "published_date": "2024-12-31T21:57:00+00:00",
              "source_hash": "4a492835170c6eddfc951da88e24004b"
            },
            {
              "url": "",
              "title": "PROCEPT BioRobotics Corporation (PRCT) Gains 40% Following Strong Q3 Earnings and Upgraded Guidance",
              "snippet": "In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ ... minimally invasive procedures to improve patient outcomes in urologic surgery.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:30.855762+00:00",
              "published_date": "2024-11-29T16:29:00+00:00",
              "source_hash": "da5e72bf90086580ac095c5d7e846c52"
            },
            {
              "url": "",
              "title": "Buy Rating for PROCEPT BioRobotics: Confidence in Growth and Profitability Prospects from Aquablation and New Product Cycle",
              "snippet": "PROCEPT BioRobotics Corp is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology. Read More on PRCT: PROCEPT BioRobotics ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Procept Biorobotics Corp Procept Biorobotics Corp patient safety controversies",
              "retrieved_at": "2025-01-06T19:31:30.855786+00:00",
              "published_date": "2024-12-03T04:46:00+00:00",
              "source_hash": "9e4e00c707ebf3ea22a68b660afc6358"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Procept Biorobotics Corp regulatory compliance issues",
              "rationale": "Investigate potential legal or regulatory challenges, including FDA or CE Mark rejections or delays",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Procept Biorobotics Corp supply chain disruptions",
              "rationale": "Assess risks related to third-party supplier dependencies and recent supply chain challenges",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Procept Biorobotics Corp patient safety controversies",
              "rationale": "Explore any reported incidents or concerns related to patient outcomes or device safety",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T12:31:46.053733",
        "data_confidence": 75,
        "pattern_confidence": null
      }
    }
  ]
}